Cargando…

Short‐Term Risk of Bleeding During Heparin Bridging at Initiation of Vitamin K Antagonist Therapy in More Than 90 000 Patients With Nonvalvular Atrial Fibrillation Managed in Outpatient Care

BACKGROUND: Several studies have recently examined the risks of bleeding and of ischemic stroke and systemic embolism associated with perioperative heparin bridging anticoagulation in patients with nonvalvular atrial fibrillation. However, few studies have investigated bridging risks during vitamin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bouillon, Kim, Bertrand, Marion, Boudali, Lotfi, Ducimetière, Pierre, Dray‐Spira, Rosemary, Zureik, Mahmoud
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2016
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5210354/ https://www.ncbi.nlm.nih.gov/pubmed/27799233 http://dx.doi.org/10.1161/JAHA.116.004065

Ejemplares similares

Paediatric outpatient prescriptions in France between 2010 and 2019: A nationwide population-based study: Paediatric outpatient prescriptions in France, 2010 to 2019
por: Taine, Marion, et al.
Publicado: (2021)

Comparison of the Short-Term Risk of Bleeding and Arterial Thromboembolic Events in Nonvalvular Atrial Fibrillation Patients Newly Treated With Dabigatran or Rivaroxaban Versus Vitamin K Antagonists: A French Nationwide Propensity-Matched Cohort Study
por: Maura, Géric, et al.
Publicado: (2015)

Pediatric Outpatient Prescriptions in Countries With Advanced Economies in the 21st Century: A Systematic Review
por: Taine, Marion, et al.
Publicado: (2022)

Association of Statins for Primary Prevention of Cardiovascular Diseases With Hospitalization for COVID‐19: A Nationwide Matched Population‐Based Cohort Study
por: Bouillon, Kim, et al.
Publicado: (2022)

Proton Pump Inhibitor Use and Risk of Serious Infections in Young Children
por: Lassalle, Marion, et al.
Publicado: (2023)

Contribution of real-life studies in France during the COVID-19 pandemic and for the national pharmaco-epidemiological surveillance of COVID-19 vaccines
por: Zureik, Mahmoud, et al.
Publicado: (2023)

Heparin bridge therapy and post-polypectomy bleeding
por: Kubo, Toshiyuki, et al.
Publicado: (2016)

Effectiveness of BNT162b2, mRNA-1273, and ChAdOx1-S vaccines against severe covid-19 outcomes in a nationwide mass vaccination setting: cohort study
por: Bouillon, Kim, et al.
Publicado: (2022)

Association between Exposure to Benzodiazepines and Related Drugs and Survivorship of Total Hip Replacement in Arthritis: A Population-Based Cohort Study of 246,940 Patients
por: Beziz, Dan, et al.
Publicado: (2016)

Is There a Cardiotoxicity Associated With Metallic Head Hip Prostheses? A Cohort Study in the French National Health Insurance Databases
por: Lassalle, Marion, et al.
Publicado: (2018)

Colonoscopy in France during the COVID-19 pandemic
por: Meyer, Antoine, et al.
Publicado: (2021)

Traitements du psoriasis et risque d’hospitalisation ou de décès pour COVID-19. Étude de cohorte à propos de 132 6312 patients atteints de psoriasis en France
por: Penso, Laetitia, et al.
Publicado: (2021)

Diminution drastique des mises en route de biomédicaments chez les patients atteints de psoriasis durant la pandémie de COVID-19 en France
por: Penso, Laetitia, et al.
Publicado: (2021)

Suicidal risk associated with finasteride versus dutasteride among men treated for benign prostatic hyperplasia: nationwide cohort study
por: Laanani, Moussa, et al.
Publicado: (2023)

Stroke, Myocardial Infarction, and Pulmonary Embolism after Bivalent Booster
por: Jabagi, Marie-Joelle, et al.
Publicado: (2023)

Utilisation des données du Système national des données de santé et/ou PMSI pour des études en lien avec la COVID-19 en France: bilan des publications scientifiques indexées dans Medline
por: Weill, A., et al.
Publicado: (2023)

Risk of hospitalisation and death related to baclofen for alcohol use disorders: Comparison with nalmefene, acamprosate, and naltrexone in a cohort study of 165 334 patients between 2009 and 2015 in France
por: Chaignot, Christophe, et al.
Publicado: (2018)

Exchangeable Femoral Neck (Dual-Modular) THA Prostheses Have Poorer Survivorship Than Other Designs: A Nationwide Cohort of 324,108 Patients
por: Colas, Sandrine, et al.
Publicado: (2017)

Profiles of copper intrauterine devices and levonorgestrel intrauterine systems users in France in 2019: A national observational population‐based study
por: Roland, Noémie, et al.
Publicado: (2022)

Reduced risk of severe COVID-19 in more than 1.4 million elderly people aged 75 years and older vaccinated with mRNA-based vaccines
por: Botton, Jérémie, et al.
Publicado: (2022)

Caractéristiques sociodémographiques et médicales associées au risque d’échec d'un schéma vaccinal deux doses contre la COVID-19 en France
por: Semenzato, L., et al.
Publicado: (2022)

Evaluation of the Incidence of Hematologic Malignant Neoplasms Among Breast Cancer Survivors in France
por: Jabagi, Marie Joelle, et al.
Publicado: (2019)

Statins for primary prevention of cardiovascular disease and the risk of acute kidney injury
por: Coste, Joël, et al.
Publicado: (2019)

Risk of Hematologic Malignant Neoplasms after Postoperative Treatment of Breast Cancer
por: Jabagi, Marie Joelle, et al.
Publicado: (2019)

Effects of the Coronavirus Disease 2019 (COVID-19) Lockdown on the Use of Contraceptives and Ovulation Inductors in France
por: Roland, Noémie, et al.
Publicado: (2021)

Mandatory Infant Vaccinations in France During the COVID-19 Pandemic in 2020
por: Taine, Marion, et al.
Publicado: (2021)

Chronic diseases, health conditions and risk of COVID-19-related hospitalization and in-hospital mortality during the first wave of the epidemic in France: a cohort study of 66 million people
por: Semenzato, Laura, et al.
Publicado: (2021)

Age and sex-specific risks of myocarditis and pericarditis following Covid-19 messenger RNA vaccines
por: Le Vu, Stéphane, et al.
Publicado: (2022)

Effectiveness of Ad26.COV2.S Vaccine vs BNT162b2 Vaccine for COVID-19 Hospitalizations
por: Botton, Jérémie, et al.
Publicado: (2022)

No association of low‐dose aspirin with severe COVID‐19 in France: A cohort of 31.1 million people without cardiovascular disease
por: Botton, Jérémie, et al.
Publicado: (2022)

Use of Proton Pump Inhibitors and Risk of Pancreatic Cancer: A Nationwide Case–Control Study Based on the French National Health Data System (SNDS)
por: Lassalle, Marion, et al.
Publicado: (2022)

Design cas témoins apparié sur score de risque : un outil méthodologique original pour une étude de l'efficacité vaccinale et des conséquences médicales de l'hospitalisation pour COVID-19 en France.
por: Semenzato, L., et al.
Publicado: (2023)

Intravitreal Anti–Vascular Endothelial Growth Factor Use in France During the Coronavirus Disease 2019 Pandemic
por: Billioti de Gage, Sophie, et al.
Publicado: (2020)

Impact of Coronavirus disease 2019 (COVID-19) on contraception use in 2020 and up until the end of April 2021 in France
por: Roland, Noémie, et al.
Publicado: (2022)

Impact of coronavirus disease 2019 on contraception use in France
por: Roland, Noémie, et al.
Publicado: (2023)

Risk of Recurrent Bleeding Events in Nonvalvular Atrial Fibrillation Treated with Vitamin K Antagonists: A Clinical Practice Research Datalink Study
por: Alikhan, Raza, et al.
Publicado: (2019)

A modified self‐controlled case series method for event‐dependent exposures and high event‐related mortality, with application to COVID‐19 vaccine safety
por: Ghebremichael‐Weldeselassie, Yonas, et al.
Publicado: (2022)

Vaccine effectiveness against severe COVID-19 outcomes within the French overseas territories: A cohort study of 2-doses vaccinated individuals matched to unvaccinated ones followed up until September 2021 and based on the National Health Data System
por: Semenzato, Laura, et al.
Publicado: (2022)

Characteristics associated with the residual risk of severe COVID-19 after a complete vaccination schedule: A cohort study of 28 million people in France
por: Semenzato, Laura, et al.
Publicado: (2022)

Oral Anticoagulants for Nonvalvular Atrial Fibrillation in Patients With High Risk of Gastrointestinal Bleeding
por: Lip, Gregory Y. H., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_vm6n2jjgjd0dmj9rkan4kamcsl